24. Moving to Market Company Indication Phase Type of nanomaterial Product Insert Therapeutics Matastatic solid IND filed Cyclodextrin nanoparticle Cyclosertcamptothecin American Pharmaceutical Partners Lung cancer, breast cancer, others NDA filed Nanoparticle albumin Abraxane ImaRx Therapeutics Oncology Preclinical Branching block copolymer self- assembled Nanoparticulate formulation of Irinotecan metabolite MRX-952 Star pharma Topical microbicide for HIV phase2 Dendrimer VivaGel
25. Advanced Magnetics Tumor imaging NDA filed Iron oxide nanoparticle Combidex Introgen Metastatic lung cancer Phase 1 Liposome INGN-401 Nanosphere Diagnostics On market DNA Functionalized Gold nanoparticles Verigene platform Triton BioSystems Solid tumors Preclinical Polymer-coated iron oxide TNT AntiEpCAM